August 5, 2022
Emergency briefing on cBHT is August 11
“FDA’s implicit threat to restrict compounded hormones is not going away,” said APC CEO Scott Brunner. “The agency could act at any moment, and we’re facing three urgent needs for action that can make a difference in slowing down the effort to restrict cBHT. We’ll provide marching orders at this briefing.”
The briefing is free, but registration required: a4pc.org/cbhtbriefing.